Missouri AG Intensifies Kratom Probe, Targets Supply Chain Amid Safety Concerns

Missouri AG Intensifies Kratom Probe, Targets Supply Chain Amid Safety Concerns

JEFFERSON CITY, MO – Missouri Attorney General Catherine Hanaway has significantly expanded her investigation into the kratom industry, announcing a new focus on the product's supply chain. This latest move builds upon earlier actions where the Attorney General's office issued Civil Investigative Demands (CIDs) to several kratom manufacturers and retailers across the state, citing concerns over "unapproved, unsafe, and deceptively marketed opioid-like drugs". The investigation aims to uncover potential violations of Missouri law and ensure consumer safety, particularly concerning products containing 7-hydroxymitragynine.

Why This Matters to Kratom Merchants and Consumers

This escalation by the Missouri Attorney General signals a period of heightened scrutiny for the kratom market in a state that currently lacks comprehensive statewide regulations for the botanical. While kratom remains legal in Missouri, efforts to establish safety standards through a Kratom Consumer Protection Act (KCPA) have faced legislative hurdles. The AG's investigation, therefore, acts as a de facto regulatory enforcement, utilizing existing consumer protection statutes to address perceived risks.

For consumers, this investigation underscores the potential dangers of unregulated kratom products, including risks of contamination, undisclosed ingredients, and inconsistent potency. The Attorney General emphasizes the public's right to know exactly what is in the products they consume.

For kratom merchants, the expansion to the supply chain means that responsibility for product safety and transparency extends beyond the retail counter. Businesses at every stage, from cultivation to distribution, could face legal challenges if their products are found to be unsafe, mislabeled, or deceptive. This creates an urgent imperative for all stakeholders to proactively ensure compliance and product integrity.

Compliance Implications

Despite the absence of a statewide KCPA, the Attorney General's actions carry significant compliance implications. Merchants are now on notice that they must be prepared to demonstrate the safety and purity of their products. Proposed KCPA legislation in Missouri indicates the direction future regulations might take, often including requirements for accredited third-party lab testing, specific alkaloid concentration limits, and comprehensive labeling. Furthermore, a bill introduced in Missouri aims to classify 7-hydroxymitragynine as a Schedule I controlled substance if its concentration exceeds 400 parts per million on a dry-weight basis, which could have profound impacts on product formulations.

What High-Risk Merchants Need to Know: COAs, Lab Testing, and Regulatory Compliance

For high-risk kratom merchants, a robust approach to product quality and compliance is no longer optional.

1. Certificates of Analysis (COAs): These documents are paramount. Merchants must obtain COAs from independent, ISO-accredited third-party laboratories for every batch of product. A credible COA should provide a comprehensive report detailing the alkaloid profile (specifically mitragynine and 7-hydroxymitragynine levels), and screen for contaminants such as heavy metals (lead, mercury, arsenic, cadmium), microbes (Salmonella, E. coli, yeast, mold), and pesticides. Importantly, COAs must be batch-specific and readily accessible to consumers, ideally via QR codes on packaging or through a dedicated section on the merchant's website.
2. Comprehensive Lab Testing: Beyond simply having a COA, the scope and integrity of the lab testing are critical. Merchants should ensure that their products undergo thorough microbiological, heavy metal, and alkaloid testing. Given the AG's focus on 7-hydroxymitragynine, verifying that products containing this alkaloid adhere to safe limits, or any proposed legal thresholds, is essential.
3. Proactive Regulatory Compliance: Even without a state KCPA, merchants should operate as if one were in place. This includes adhering to Good Manufacturing Practices (GMP), ensuring accurate and transparent labeling, avoiding adulterated products, and implementing age restrictions (e.g., no sales to individuals under 18). Vetting suppliers thoroughly to ensure their compliance with these standards is also crucial, especially with the investigation targeting the entire supply chain. Maintaining product liability insurance, as suggested in proposed legislation, is a prudent business practice.

This expanded investigation by the Missouri Attorney General is a clear signal to the kratom industry that consumer protection and product safety are top priorities. Merchants who prioritize transparency, rigorous testing, and proactive compliance will be best positioned to navigate this evolving regulatory landscape.